End Cash: The amount of cash held by the company for the given period.
Chemomab Therapeutics Ltd. Sponsored ADR (CMMB) End Cash data is not available for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-3.32M |
|
-- |
|
-- |
|
$3.49M |
|
$-3.49M |
|
$0.16M |
|
$-3.32M |
|
$-3.32M |
|
$-3.32M |
|
$-3.32M |
|
$-3.32M |
|
$-3.32M |
|
$-3.49M |
|
$-3.49M |
|
22.81M |
|
22.81M |
|
$-0.14 |
|
$-0.14 |
|
| Balance Sheet Financials | |
$11.98M |
|
$0.24M |
|
$0.84M |
|
$12.82M |
|
$2.25M |
|
-- |
|
$0.18M |
|
$2.43M |
|
$10.39M |
|
$10.39M |
|
$10.39M |
|
18.86M |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
|
End Cash |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.33 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-31.97% |
|
-31.97% |
|
-25.92% |
|
-31.97% |
|
$0.55 |
|
-- |
|
-- |
|